S T A T E M E N T   O F   I N V E S T M E N T S   S e p t e m b e r   3 0 ,   2 0 2 3   ( U n a u d i t e d )

 

General American Investors

 

            Value 
  Shares   COMMON STOCKS     (Note 1a) 
Communication Services (7.9%)   Media and Entertainment (6.6%)       
 444,923   Alphabet Inc. - Class C (a)      $58,663,097 
 1,187,369   Angi Inc. - Class A (a)       2,350,991 
   22,000   Meta Platforms, Inc. - Class A (a)       6,604,620 
   111,478   The Walt Disney Company (a)       9,035,292 
          (Cost $36,797,556)    76,654,000 
   Telecommunication Services (1.3%)         
   501,392   AT&T Inc.       7,530,908 
   274,199   GCI Liberty, Inc. Escrow (a)        
   57,848   T-Mobile US, Inc. (a)       8,101,612 
          (Cost $15,319,343)    15,632,520 
          (Cost $52,116,899)    92,286,520 
                 
Consumer Discretionary (10.2%)  Consumer Durables and Apparel (0.6%)         
 70,000   NIKE, Inc. - Class B  (Cost $7,254,790)    6,693,400 
               
   Consumer Services (1.7%)         
   198,157   Expedia Group, Inc. (a)  (Cost $23,537,231)    20,424,042 
                 
   Distribution and Retail (7.9%)         
   286,000   Amazon.com, Inc. (a)       36,356,320 
   264,592   Bath & Body Works, Inc.       8,943,210 
   525,092   The TJX Companies, Inc.       46,670,177 
          (Cost $20,712,703)    91,969,707 
          (Cost $51,504,724)    119,087,149 
                 
Consumer Staples (9.7%)  Distribution and Retail (2.6%)         
 53,000   Costco Wholesale Corporation  (Cost $1,601,596)    29,942,880 
               
   Food, Beverage and Tobacco (5.2%)         
   325,000   Nestlé S.A. (Switzerland)       36,833,452 
   140,000   PepsiCo, Inc.       23,721,600 
          (Cost $15,322,831)    60,555,052 
   Household and Personal Products (1.9%)         
   438,936   Unilever PLC (Netherlands/United Kingdom)  (Cost $12,513,080)    21,757,693 
          (Cost $29,437,507)    112,255,625 
                 
Energy (5.6%)  619,230   Cameco Corporation (Canada)       24,546,277 
 81,991   Chevron Corporation       13,825,322 
   1,020,030   Energy Transfer LP       14,311,021 
   1,173,370   Gulf Coast Ultra Deep Royalty Trust       17,307 
   83,512   Hess Corporation       12,777,336 
          (Cost $29,807,234)    65,477,263 
                 
Financials (20.8%)  Banks (2.1%)         
 80,000   JPMorgan Chase & Co.       11,601,600 
   100,000   M&T Bank Corporation       12,645,000 
          (Cost $3,188,933)    24,246,600 
   Financial Services (6.9%)         
   110   Berkshire Hathaway Inc. - Class A (a)(b)       58,462,470 
   243,415   Nelnet, Inc. - Class A       21,741,828 
          (Cost $2,968,650)    80,204,298 
   Insurance (11.8%)         
   750,249   Arch Capital Group Ltd. (a) (Bermuda)       59,802,348 
   285,081   Axis Capital Holdings Limited (Bermuda)       16,070,016 
   129,196   Everest Group, Ltd. (Bermuda)       48,018,277 
   220,327   MetLife, Inc.       13,860,772 
          (Cost $30,473,465)    137,751,413 
          (Cost $36,631,048)    242,202,311 

 

1

 

 

 

 

S T A T E M E N T  O F  I N V E S T M E N T S  S e p t e m b e r  3 0 ,   2 0 2 3  ( U n a u d i t e d )  -  c o n t i n u e d

 

General American Investors

 

                      Value  
    Shares     COMMON STOCKS (continued)           (Note 1a)  
Health Care (9.8%)   Equipment and Services (2.0%)              
  37,500     The Cigna Group         $ 10,727,625  
    70,000     Medtronic plc (Ireland)           5,485,200  
    110,000     Tenet Healthcare Corporation (a)           7,247,900  
              (Cost $23,228,482)       23,460,725  
    Pharmaceuticals, Biotechnology and Life Sciences (7.8%)              
    50,010     Danaher Corporation           12,407,481  
    119,900     Gilead Sciences, Inc.           8,985,306  
    260,439     Intra-Cellular Therapies, Inc. (a)           13,566,267  
    179,326     Merck & Co., Inc.           18,461,612  
    365,808     Pfizer Inc.           12,133,851  
    119,250     Quantum-Si Incorporated - Class A (a)           197,955  
    16,576     Regeneron Pharmaceuticals, Inc. (a)           13,641,385  
    971,131     SIGA Technologies, Inc.           5,098,438  
    450,000     SomaLogic, Inc. - Class A (a)           1,075,500  
    223,201     Valneva SE (a) (France)           1,306,853  
    345,000     Valneva SE ADR (a) (France)           4,071,000  
    62,583     VBI Vaccines, Inc. (a) (Canada)           41,693  
              (Cost $60,265,097)       90,987,341  
              (Cost $83,493,579)       114,448,066  
                         
Industrials (9.4%)   Capital Goods (3.0%)              
  862,873     BAE Systems plc (United Kingdom)           10,504,751  
    56,200     Eaton Corporation plc (Ireland)           11,986,336  
    165,000     Raytheon Technologies Corporation           11,875,050  
              (Cost $19,452,115)       34,366,137  
    Commercial and Professional Services (6.4%)              
    524,895     Republic Services, Inc.   (Cost $7,346,689)       74,802,786  
              (Cost $26,798,804)       109,168,923  
                         
Information Technology (23.5%)   Semiconductors and Semiconductor Equipment (8.6%)              
  383,364     AIXTRON SE (Germany)           14,112,951  
  61,652     Applied Materials, Inc.           8,535,719  
    74,600     ASML Holding N.V. (Netherlands)           43,914,036  
    21,500     Broadcom Inc.           17,857,470  
    935,064     indie Semiconductor, Inc. - Class A (a)           5,890,903  
    65,009     Universal Display Corporation           10,205,763  
              (Cost $29,115,863)       100,516,842  
    Software and Services (8.7%)              
    25,000     Adobe Inc. (a)           12,747,500  
    215,000     Microsoft Corporation           67,886,250  
    1,251,361     NextNav Inc. (a)           6,431,996  
    36,381     Tyler Technologies, Inc. (a)           14,048,159  
              (Cost $31,095,645)       101,113,905  
    Technology, Hardware and Equipment (6.2%)              
    321,000     Apple Inc.           54,958,410  
    25,000     Arista Networks, Inc. (a)           4,598,250  
    223,260     Cisco Systems, Inc.           12,002,458  
              (Cost $8,787,144)       71,559,118  
              (Cost $68,998,652)       273,189,865  
                         
Materials (4.7%)   524,528     Agnico Eagle Mines Limited (Canada)           23,839,798  
  932,438     Alamos Gold Inc. - Class A (Canada)           10,527,225  
    970,960     Algoma Steel Group Inc. (Canada)           6,602,528  
    243,593     Cleveland-Cliffs Inc. (a)           3,807,359  
    928,591     Ferroglobe PLC (United Kingdom) (a)           4,828,673  
    198,248     Huntsman Corporation           4,837,251  
              (Cost $58,841,694)       54,442,834  

 

2

 

 

 

 

S T A T E M E N T  O F  I N V E S T M E N T S  S e p t e m b e r  3 0 ,  2 0 2 3  ( U n a u d i t e d )  -  c o n t i n u e d

 

General American Investors

 

              Value 
   Shares   COMMON STOCKS (continued)      (Note 1a) 
Miscellaneous (0.5%)   360,635   Other (c)   (Cost $8,694,137)   $6,391,393 
                   
        TOTAL COMMON STOCKS (102.1%)   (Cost $446,324,278)    1,188,949,949 
                   
        PURCHASED OPTIONS (a)          
                  
   Contracts   Company/Expiration Date/          
Puts  (100 Shares Each)   Exercise Price/Notional          
Capital Goods (0.0%)   562   Eaton Corporation plc/October 20, 2023/$185/$10,397,000   (Cost $426,351)     
                   
Commercial and Professional Services (0.0%)   500   Republic Services, Inc./October 20, 2023/$140/$7,000,000   (Cost $196,205)    65,000 
                   
Technology, Hardware and Equipment (0.0%)   1,000   Apple Inc./Octboer 20, 2023/$170/$17,000,000   (Cost $221,654)    276,000 
                  
       TOTAL PURCHASED OPTIONS (0.0%)   (Cost $844,210)    341,000 
                   
   Principal   SHORT-TERM SECURITIES          
        U.S. Treasury Bills          
   $25,000,000   Due November 2, 2023, 5.265% (d)        24,883,000 
    25,000,000   Due January 25, 2024, 5.285% (d)        24,574,340 
            (Cost $49,457,264)    49,457,340 
                   
   Shares              
    123,485,555   State Street Institutional Treasury Plus Money Market Fund, Trust Class, 5.23% (e)   (Cost $123,485,555)    123,485,555 
                   
        TOTAL SHORT-TERM SECURITIES (14.9%)   (Cost $172,942,819)    172,942,895 
                   
TOTAL INVESTMENTS (f) (117.0%)   (Cost $620,111,307)    1,362,233,844 
Liabilities in excess of other assets (-0.7%)        (8,161,819)
                 1,354,072,025 
PREFERRED STOCK (-16.3%)        (190,117,175)
NET ASSETS APPLICABLE TO COMMON STOCK (100%)       $1,163,954,850 

 

ADR - American Depository Receipt 

(a)Non-income producing security.
(b)50 shares of 110 total shares held as collateral for options written.
(c)Securities which have been held for less than one year, not previously disclosed, and not restricted.
(d)Yield to maturity at purchase.
(e)7-day yield.
(f)At September 30, 2023, the cost of investments and derivatives for Federal income tax purposes was $618,511,612; aggregate gross unrealized appreciation was $772,394,939; aggregate gross unrealized depreciation was $29,701,369; and net unrealized appreciation was $742,693,570.

 

S T A T E M E N T  O F  O P T I O N S  W R I T T E N  S e p t e m b e r  3 0 ,  2 0 2 3  ( U n a u d i t e d )

 
   Contracts   Company/Expiration Date/  Premiums   Value 
Calls  (100 Shares Each)   Exercise Price/Notional  Received*   (Note 1a) 
Capital Goods (0.1%)   362   Eaton Corporation plc/October 20, 2023/$200/$7,240,000  $224,545   $564,720 
                   
Commercial and Professional Services (0.0%)   64   Republic Services, Inc./October 20, 2023/$165/$1,056,000   9,857    2,560 
                   
Puts                  
Pharmaceuticals, Biotechnology and Life Sciences (0.0%)    144   Madrigal Pharmaceuticals, Inc./October 20, 2023/$180/$2,592,000   179,606    525,600 
                  
       TOTAL OPTIONS WRITTEN (0.1%)  $414,008   $1,092,880 

 

*The maximum cash outlay if all options are exercised is $10,888,000.

 

(see notes to unaudited financial statements)

 

3

 

 

 

 

N O T E S  T O  F I N A N C I A L  S TAT E M E N T S  ( U n a u d i t e d )

 

General American Investors

 

1.  Significant Accounting Policies and Other Matters – General American Investors Company, Inc. (the “Company”), established in 1927, is registered under the Investment Company Act of 1940 as a closed-end, diversified management investment company. It is internally managed by its officers under the direction of the Board of Directors.

 

The accompanying financial statements have been prepared in accordance with United States generally accepted accounting principles (“U.S. GAAP”) pursuant to the requirements for reporting; Accounting Standards Codification 946, Financial Services – Investment Companies (“ASC 946”), and Regulation S-X.

 

The preparation of financial statements in accordance with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of income, expenses, and gains and losses during the reported period. Changes in the economic environment, financial markets, and any other parameters used in determining these estimates could cause actual results to differ, and these differences could be material.

 

a.  Security Valuation   Equity securities traded on a national securities exchange are valued at the last reported sales price on the last business day of the period. Equity securities reported on the NASDAQ national market are valued at the official closing price on that day. Listed and NASDAQ equity securities for which no sales are reported on that day and other securities traded in the over-the-counter market are valued at the last bid price (asked price for options written) on the valuation date. Equity securities traded primarily in foreign markets are valued at the closing price of such securities on their respective exchanges or markets. Corporate debt, domestic and foreign, and U.S. government securities are generally traded in the over-the-counter market rather than on a national securities exchange. The Company utilizes the latest bid prices furnished by independent pricing services with respect to transactions in such securities to determine current market value if maturity date exceeds 60 days. Investments in such securities maturing within 60 days or less are valued at amortized cost. If, after the close of foreign markets, conditions change significantly, the price of certain foreign securities may be adjusted to reflect fair value as of the time of the valuation of the portfolio. Investments in money market funds are valued at their net asset value.

 

b. Options   The Company may purchase and write (sell) exchange traded put and call options on equity securities. The Company purchases put options or writes call options to hedge the value of portfolio investments while it purchases call options and writes put options to obtain market exposure. The risk associated with purchasing an option is that the Company pays a premium whether or not the option is exercised. Additionally, the Company bears the risk of loss of the premium and a change in market value should the counterparty not perform under the contract. Put and call options purchased are accounted for in the same manner as portfolio securities. Premiums received from writing options are reported as a liability on the Statement of Assets and Liabilities. Those that expire unexercised are treated by the Company on the expiration date as realized gains on written option transactions in the Statement of Operations. The difference between the premium received and the amount paid on effecting a   closing purchase transaction, including brokerage commissions, is also treated as a realized gain, or, if the premium is less than the amount paid for the closing purchase transaction, as a realized loss on written option transactions in the Statement of Operations. If a written call option is exercised, the premium is added to the proceeds from the sale of the underlying security in determining whether the Company has realized a gain or loss on investments in the Statement of Operations. If a written put option is exercised, the premium reduces the cost basis of the securities purchased by the Company and is parenthetically disclosed on the Statement of Assets and Liabilities. The Company as writer of an option bears the market risk of an unfavorable change in the price of the security underlying the written option. For exchange traded options purchased, the Company bears the risk of loss in the amount of the premiums paid plus appreciation in market value should a counterparty fail to perform under the contract. Options written by the Company do not give rise to counterparty risk as options written obligate the Company to perform. The Company has not entered into a master netting agreement with respect to options on equity securities. See Note 4 for option information.

 

c. Security Transactions and Investment Income   Security transactions are recorded as of the trade date. Realized gains and losses are determined on the specific identification method. Dividend income and distributions to stockholders are recorded as of the ex-dividend dates. Interest income is recognized daily on the accrual basis, adjusted for the accretion of discounts and amortization of premiums.

 

4

 

 

 

  

N O T E S  T O  F I N A N C I A L  S TAT E M E N T S  ( U n a u d i t e d )  -  c o n t i n u e d

 

General American Investors

 

1. Significant Accounting Policies and Other Matters - (Continued from bottom of previous page.)

 

d. Foreign Currency Translation and Transactions   Portfolio securities and other assets and liabilities denominated in foreign currencies are translated into U.S. dollars based on the exchange rate of such currencies versus U.S. dollars on the date of valuation. Purchases and sales of securities, income and expense items denominated in foreign currencies are translated into U.S. dollars at the exchange rate in effect on the transaction date. Events may impact the availability or reliability of foreign exchange rates used to convert the U.S. dollar equivalent value. If such an event occurs, the foreign exchange rate will be valued at fair value using procedures established and approved by the Company’s Board of Directors. The Company does not separately report the effect of changes in foreign exchange rates from changes in market prices on securities held. These changes are combined and included in net realized and unrealized gain or loss on the Statement of Operations.

 

Realized foreign exchange gains or losses may also arise from sales of foreign currencies, currency gains or losses realized between the trade and settlement dates on securities transactions and the difference between the recorded amounts of dividends, interest, and foreign withholding taxes and the U.S. dollar equivalent of the amounts actually received or paid. Net unrealized foreign exchange gains and losses may also arise from changes in foreign exchange rates on foreign currency denominated assets and liabilities other than investments in securities held at the end of the reporting period.

 

Foreign security and currency transactions may involve certain considerations and risks not typically associated with those of U.S. companies as a result of, among other factors, the possibility of political or economic instability or the level of governmental supervision and regulation of foreign securities markets.

 

e. Dividends and Distributions   The Company expects to pay dividends of net investment income and distributions of net realized capital and currency gains, if any, annually to common shareholders and quarterly to preferred shareholders. Dividends and distributions to common and preferred shareholders, which are determined in accordance with Federal income tax regulations, are recorded on the ex-dividend date. Permanent book/tax 11 differences relating to income and gains are reclassified to paid-in capital as they arise.

 

f.  Federal Income Taxes   The Company’s policy is to fulfill the requirements of the Internal Revenue Code applicable to regulated investment companies and to distribute substantially all taxable income to its stockholders. Accordingly, no provision for Federal income taxes is required. In accordance with U.S. GAAP requirements regarding accounting for uncertainties in income taxes, management has analyzed the Company’s tax positions taken or expected to be taken on Federal and state income tax returns for all open tax years (the current and the prior three tax years) and has concluded that no provision for income tax is required in the Company’s financial statements.

 

g. Indemnifications   In the ordinary course of business, the Company enters into contracts that contain a variety of indemnifications. The Company’s maximum exposure under these arrangements is unknown. However, the Company has not had prior claims or losses pursuant to these indemnification provisions and expects any future risk of loss thereunder to be remote.

 

2.  Fair Value Measurements – Various data inputs are used in determining the value of the Company’s investments. These inputs are summarized in a hierarchy consisting of the three broad levels listed below:

 

Level 1 - quoted prices in active markets for identical securities (including money market funds which are valued at net asset value, typically $1 per share),

 

Level 2 - other significant observable inputs (including quoted prices for similar securities, interest rates, etc.), and

 

Level 3 - significant unobservable inputs (including assumptions in determining the fair value of investments).

 

The inputs or methodology used for valuing securities are not necessarily an indication of the risk associated with investing in those securities. No transfers among levels occurred during the nine months ended September 30, 2023. The following is a summary of the inputs used to value the Company’s net assets as of September 30, 2023:

 

Assets  Level 1  Level 2  Level 3  Total 
Common stocks  $1,188,949,949        $1,188,949,949 
Purchased options   341,000         341,000 
U.S. Treasury bills     $49,457,340      49,457,340 
Money market fund   123,485,555         123,485,555 
Total  $1,312,776,504  $49,457,340     $1,362,233,844 
                  
Liabilities                 
Options written  $1,092,880        $1,092,880 

 

5

 

 


General American Investors (NYSE:GAM-B)
과거 데이터 주식 차트
부터 4월(4) 2024 으로 5월(5) 2024 General American Investors 차트를 더 보려면 여기를 클릭.
General American Investors (NYSE:GAM-B)
과거 데이터 주식 차트
부터 5월(5) 2023 으로 5월(5) 2024 General American Investors 차트를 더 보려면 여기를 클릭.